Managing the risks of making the wrong diagnosis: First, do no harm

by Piero Olliaro, Els Torreele
Published 2021-05-01

COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room

by Piero Olliaro, Els Torreele, Michel Vaillant
Published 2021-07-01

COVID-19 vaccines: effectiveness and number needed to treat – Authors' reply

by Piero Olliaro, Els Torreele, Michel Vaillant
Published 2021-07-01

More efficient ways of assessing treatments for neglected tropical diseases are required: innovative study designs, new endpoints, and markers of effects.

by Piero Olliaro, Michel T Vaillant, Shyam Sundar, Manica Balasegaram
Published 2012-01-01

Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations

by Lakshmi Manoharan, Piero Olliaro, Peter W. Horby, Conall H. Watson
Published 2021-05-01

A comparison of Zika and dengue outbreaks using national surveillance data in the Dominican Republic.

by Leigh R Bowman, Joacim Rocklöv, Axel Kroeger, Piero Olliaro, Ronald Skewes
Published 2018-11-01

Time to reconsider the role of ribavirin in Lassa fever.

by Alex Paddy Salam, Vincent Cheng, Tansy Edwards, Piero Olliaro, Jonathan Sterne, Peter Horby
Published 2021-07-01

Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review.

by Siddhivinayak Hirve, Marleen Boelaert, Greg Matlashewski, Dinesh Mondal, Byron Arana, Axel Kroeger, Piero Olliaro
Published 2016-08-01

Resolution of praziquantel.

by Michael Woelfle, Jean-Paul Seerden, Jesse de Gooijer, Kees Pouwer, Piero Olliaro, Matthew H Todd
Published 2011-09-01

Potential drug development candidates for human soil-transmitted helminthiases.

by Piero Olliaro, Jürg Seiler, Annette Kuesel, John Horton, Jeffrey N Clark, Robert Don, Jennifer Keiser
Published 2011-06-01

Clinical REsearch During Outbreaks (CREDO) Training for Low- and Middle-Income Countries

by Nzelle Delphine Kayem, Amanda Rojek, Emmanuelle Denis, Alex Salam, Andreas Reis, Piero Olliaro, Peter Horby
Published 2019-11-01

Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent.

by Filip Meheus, Manica Balasegaram, Piero Olliaro, Shyam Sundar, Suman Rijal, Md Abul Faiz, Marleen Boelaert
Published 2010-09-01

Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse

by Dinesh Mondal, Prakash Ghosh, Rajashree Chowdhury, Christine Halleux, Jose A. Ruiz-Postigo, Abdul Alim, Faria Hossain, Md Anik Ashfaq Khan, Rupen Nath, Malcolm S. Duthie, Axel Kroeger, Greg Matlashewski, Daniel Argaw, Piero Olliaro, Piero Olliaro
Published 2019-10-01

The Lipid Moiety of Haemozoin (Malaria Pigment) and P. falciparum Parasitised Red Blood Cells Bind Synthetic and Native Endothelin-1

by Nicoletta Basilico, Silvia Parapini, Francesca Sisto, Fausta Omodeo-Salè, Paolo Coghi, Fernando Ravagnani, Piero Olliaro, Donatella Taramelli
Published 2010-01-01

Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis.

by Piero Olliaro, Michel Vaillant, Byron Arana, Max Grogl, Farrokh Modabber, Alan Magill, Olivier Lapujade, Pierre Buffet, Jorge Alvar
Published 2013-01-01

Towards elimination of visceral leishmaniasis in the Indian subcontinent-Translating research to practice to public health.

by Siddhivinayak Hirve, Axel Kroeger, Greg Matlashewski, Dinesh Mondal, Megha Raj Banjara, Pradeep Das, Ahmed Be-Nazir, Byron Arana, Piero Olliaro
Published 2017-10-01

Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: A systematic review, meta-analysis and individual patient data analysis.

by Marta S Palmeirim, Eveline Hürlimann, Stefanie Knopp, Benjamin Speich, Vicente Belizario, Serene A Joseph, Michel Vaillant, Piero Olliaro, Jennifer Keiser
Published 2018-04-01

High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure

by Rajeev K. Tyagi, Patrick J. Gleeson, Ludovic Arnold, Rachida Tahar, Eric Prieur, Laurent Decosterd, Jean-Louis Pérignon, Piero Olliaro, Pierre Druilhe
Published 2018-10-01

What can National TB Control Programmes in low- and middle-income countries do to end tuberculosis by 2030? [version 1; referees: 2 approved]

by Anthony D. Harries, Yan Lin, Ajay M.V. Kumar, Srinath Satyanarayana, Kudakwashe C. Takarinda, Riitta A. Dlodlo, Rony Zachariah, Piero Olliaro
Published 2018-07-01

A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gam...

by Freddie Kansiime, Seraphine Adibaku, Charles Wamboga, Franklin Idi, Charles Drago Kato, Lawrence Yamuah, Michel Vaillant, Deborah Kioy, Piero Olliaro, Enock Matovu
Published 2018-02-01